Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Anticancer Research|May 31, 2024
DNA-Binding Agent Trabectedin Combined With Recombinant Methioninase Is Synergistic to Decrease Fibrosarcoma Cell Viability and Induce Nuclear Fragmentation But Not Synergistic on Normal FibroblastsSei Morinaga, Qinghong Han, Yutaro Kubota, et al.
Cancer Diagnosis & Prognosis|May 5, 2025
Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA)Yohei Asano, Yutaka Yonemura, Chihiro Hozumi, et al.
Anticancer Research|October 28, 2025
Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal FibroblastsYohei Asano, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)|February 27, 2026
Ultra-low Concentrations of Cisplatinum Down to the IC10 in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells In Vitro and In VivoYohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research|October 28, 2025
Very Rapid Eradication of a Large Squamous-Cell Carcinoma of the Head and Neck Treated With First-line Combination Chemotherapy, a Low-methionine Diet, and Oral Recombinant MethioninaseYohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research|November 29, 2025
Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal FibroblastsYohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research|June 27, 2025
The Combination of the Autophagy Inhibitor Chloroquine and Recombinant Methioninase Has Selective Synergistic Efficacy on Human Colon Cancer Cells But Not on Normal Human FibroblastsYohei Asano, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)|June 30, 2026
Synergy of a Low-methionine Diet and Reduced-dose Cisplatinum Eradicates Experimental Lung-cancer Bone Metastases in a Nude-mouse ModelYohei Asano, Kohei Mizuta, Yuta Miyashi, et al.
Oncology Letters|May 8, 2023
A validation study for the utility of serum microRNA as a diagnostic and prognostic marker in patients with osteosarcomaYoshihiro Araki, Naofumi Asano, Norio Yamamoto, et al.
Anticancer Research|November 29, 2025
FDG- and MET-PET Imaging Reveal Glucose and Methionine Addiction in a Primary Endometrial Cancer and Methionine Addiction only in a Para-aortic Lymph-node Metastasis in a 58-year-old PatientYohei Asano, Toshihiko Sato, Chihiro Hozumi, et al.
Pageof 12